3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
7
Carcinoma, Non-Small-Cell Lung
4
Triple Negative Breast Neoplasms
3
Hodgkin Disease
3
Rhabdomyosarcoma, Embryonal
2
Rhabdomyosarcoma, Alveolar
2
Rhabdomyosarcoma
2
Neoplasm Metastasis
2
Uterine Cervical Neoplasms
1
Sarcoma
1
Recurrence
1
Neoplasms
1
Lung Neoplasms
1
Lung Diseases, Interstitial
1
HR+HER2- Breast Cancer
1
Desmoplastic Small Round Cell Tumor
1
Adenocarcinoma
1
Interventions
ribociclib
3
abemaciclib
3
Fulvestrant
3
Anastrozole
3
palbociclib
2
exemestane
2
Tamoxifen
2
Letrozole
2
AZD9833
2
trastuzumab deruxtecan
1
taxane
1
pertuzumab
1
elacestrant
1
dalpiciclib
1
Trastuzumab
1
STX-478
1
RAD1901
1
Metformin
1
Leflunomide
1
Imlunestrant
1
Gonadotropin-Releasing Hormone
1
Genotype
1
Body Height
1
Blood Pressure
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Breast Diseases
×
Vinorelbine
×
90 days
×
Clear all
No trials found.